Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDA-II: Polyglucoferron vs Ferric Carboxymaltose and Oral Iron in Postoperative Iron Deficiency Anaemia
NCT03817957Phase 3Completed
- Start
- Sep 2018
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in iron deficiency anemia (IDA) (3 arms). Primary endpoints: Proportion of patients who achieve normalized Hb-levels or increased Hb of at least 1.5 g/dl at 30 days and Pre-post difference of volume-corrected urine iron levels. Started Sep 2018; status: completed.
02
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03817957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03817957.